Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Entropy Technologies LP

Entropy Technologies LP lifted its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 162.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,302 shares of the company's stock after acquiring an additional 9,467 shares during the period. Entropy Technologies LP's holdings in Doximity were worth $817,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. UMB Bank n.a. increased its position in shares of Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after acquiring an additional 235 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after acquiring an additional 603 shares during the last quarter. Morse Asset Management Inc acquired a new stake in shares of Doximity in the third quarter worth $46,000. GAMMA Investing LLC increased its position in Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock worth $63,000 after acquiring an additional 412 shares during the period. Finally, Covestor Ltd increased its position in Doximity by 441.9% during the third quarter. Covestor Ltd now owns 1,680 shares of the company's stock worth $73,000 after acquiring an additional 1,370 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Stock Performance

DOCS stock traded up $0.14 during midday trading on Friday, reaching $77.13. 2,886,369 shares of the company traded hands, compared to its average volume of 1,531,451. The business has a 50 day moving average of $57.89 and a 200-day moving average of $47.50. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The firm has a market capitalization of $14.40 billion, a price-to-earnings ratio of 77.13, a P/E/G ratio of 4.61 and a beta of 1.39.

Insiders Place Their Bets

In other news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 37.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

DOCS has been the topic of several research reports. Wells Fargo & Company upped their price target on shares of Doximity from $43.00 to $55.00 and gave the stock an "equal weight" rating in a research report on Friday, February 7th. Canaccord Genuity Group cut Doximity from a "buy" rating to a "hold" rating and increased their target price for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Leerink Partnrs raised Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Canaccord Genuity Group raised their price target on shares of Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research note on Friday, February 7th. Finally, Morgan Stanley raised shares of Doximity from an "underweight" rating to an "equal weight" rating and raised their price target for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.